Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet polymorphisms in thrombotic disorders.

S Santoso1

  • 1Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig University Giessen, Germany. sentot.santoso@immunologie.med.uni-giessen.de

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|August 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alloimmunization against platelet-specific antigen Dik on glycoprotein IIb in a case of fetal-neonatal alloimmune thrombocytopenia.

Transfusion·2025
Same author

Psychotherapeutic modalities for phantom limb pain: a scoping review.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2025
Same author

Assessment of HNA alloimmunisation risk in Northeastern Thais, Burmese and Karen.

Transfusion medicine (Oxford, England)·2017
Same author

Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.

Transfusion medicine (Oxford, England)·2017
Same author

The prevalence of leucocyte alloantibodies in blood donors from South China.

Transfusion medicine (Oxford, England)·2016
Same author

Two cases of platelet transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China.

Transfusion medicine (Oxford, England)·2014
Same journal

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

Genetic variations in platelet receptors, like glycoprotein GPIb-IX-V and integrin alphaIIb beta3, influence thrombotic risk. Understanding these genetic differences is key to assessing coronary heart disease risk.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Genetics

Background:

  • Plaque rupture and endothelial damage expose von Willebrand factor (VWF) and collagen.
  • Platelet adhesion to VWF (via GPIb-IX-V) and collagen (via integrin alpha2 beta1) initiates thrombus formation.
  • Platelet activation leads to integrin alphaIIb beta3 conformational change, promoting fibrinogen binding and aggregation.

Purpose of the Study:

  • To review the impact of platelet receptor gene polymorphisms on thrombotic risk.
  • To explore the relationship between genetic variations in platelet glycoproteins and coronary heart disease (CHD) risk.
  • To provide a comprehensive overview of current literature in this rapidly evolving field.

Main Methods:

  • Literature review focusing on genetic variations in platelet receptors.

Related Experiment Videos

  • Analysis of studies investigating the association between platelet glycoprotein polymorphisms and thrombotic events.
  • Synthesis of findings on how genetic differences affect receptor function and disease risk.

    • Main Results:

    • Genetic variations in key platelet receptors (e.g., GPIb-IX-V, alpha2 beta1, alphaIIb beta3) can alter their surface expression or activity.
    • These alterations can influence the hemostatic process and consequently impact an individual's risk for adverse thrombotic events.
    • A growing body of literature links specific platelet glycoprotein polymorphisms to coronary heart disease risk.

    Conclusions:

    • Genetic polymorphisms in platelet receptors play a significant role in modulating thrombotic risk.
    • Understanding these genetic factors is crucial for risk stratification and potentially for developing targeted therapeutic strategies.
    • Further research is warranted to fully elucidate the complex interplay between platelet genetics and cardiovascular outcomes.